Summary report of swissethics on the work of the ethics committees from March to June 2020, due to to the Covid-19 pandemic
Selection of publications on COVID-19 pandemic (research, perspectives, ethics, ...)
In chronological order of publication
What Covid Has Taught the World about Ethics. E.J. Emanuel et al. NEJM, October 27, 2022 (Link)
SARS-CoV-2 Human Challenge Studies - Establishing the Model during an Evolving Pandemic. G. Rapeport, M.B. et al. NEJM, September 9, 2021 (Link)
On the Shoulders of Giants — From Jenner’s Cowpox to mRNA Covid Vaccines.
A. Desmond, P. A. Offit, NEJM, March 20, 2021 (Link)
Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs.
F. Rodgers, T. Pepperrell, S. Keestra et al. BMC Trials 22, 59, January 15, 2021 (Link)
Placebo-Controlled trials of Covid-19 vaccines - Why we still need them
WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation, NEJM, December 2, 2020 (Link)
The WHO's COVID-19 clinical trial is 'adaptive'. What does that mean?
Innovative Medicine Initiative, Newsroom, November 6, 2020 (Link)
When will We have a vaccine? - Undertanding Questions and Answers about Covid-19 Vaccination
B.R. Bloom, G.J. Nowak, W. Orenstein, NEJM, September 8, 2020 (Link)
Ethics of controlled human infection to address COVID-19
S.K. Shah, et. al., Science, May 22, 2020 (Link)
Werden ethische und wissenschaftliche Standards in Krisenzeiten über Bord geworfen?
P. Kleist, Zürcher Zentrum für Integrative Humanphysiologie (ZIHP), May 19, 2020 (Link)
Clinical trials for Covid-19: can we better use the short window of opportunity?
H.-G. Eichler et al. ASCPT, May 14, 2020 (Link)
Consider pregnancy in COVID-19 therapeutic drug and vaccine trials
C.L. Whitehead, S.P. Walker, The Lancet, May 13, 2020 (Link)
Waste in Covid-19 research
Paul P Glasziou, BMJ, May 12, 2020 (Link)
Key criteria for the ethical acceptability of COVID-19 human challenge studies. WHO Working Group for Guidance on Human Challenge Studies in COVID-19, WHO, May 6, 2020 (Link)
Randomized Clinical Trials and COVID-19 Managing Expectations
H. Bauchner, P.B. Fontanarosa, JAMA, published online May 4, 2020 (Link)
Position of the European Network of Research Ethics Committees (EUREC) on the Responsibility of Research Ethics Committees during the COVID-19 Pandemic, April 27, 2020 (Link)
Against pandemic research exceptionalism
A.J. London, J. Kimmelman. Science, April 23, 2020 (Link)
Audio Interview: Approaches to Covid-19 Vaccines and Antiviral
E.J. Rubin, L.R. Baden, S. Morrissey. NEJM, April 23, 2020 (Link)
Endothelial cell infection and endotheliitis in COVID-19
Varga Z. et al. Lancet, published online April 17, 2020 (Link)
Drug Evaluation during the Covid-19 Pandemic
B.J. Rome, J. Avorn. NEJM, April 14, 2020 (Link)
Viewpoint: COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation
M. Salathé et al. Swiss Med Wkly. March 19, 2020 (Link)
Nuffield Council on Bioethics. Webinar 'Ethics in the research response to COVID-19'
April 3, 2020 (Link)
Preserving Clinical Trial Integrity During the Coronavirus Pandemic
McDermott MM, Newman AB. JAMA, March 25, 2020 (Link)
Viewpoint: Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
A.C. Kalil, JAMA, March 24, 2020 (Link)
WHO launches global megatrial of the four most promising coronavirus treatments
Kai Kupfermschmidt, John Cohen, Science, March 22, 2020 (Link)
Responding to Covid-19 — A Once-in-a-Century Pandemic?
Bill Gates. NEJM, first published online February 28, 2020 (Link)
Ethical Criteria for Human Challenge Studies in Infectious Diseases
B. Bambery et al., Public Health Ethics, first published online September 27, 2015 (Link)